Previous close | 159.00 |
Open | 158.00 |
Bid | 0.00 x 20000 |
Ask | 0.00 x 20000 |
Day's range | 158.00 - 158.00 |
52-week range | 115.00 - 168.00 |
Volume | |
Avg. volume | 6 |
Market cap | 10.524B |
Beta (5Y monthly) | 1.26 |
PE ratio (TTM) | 14.47 |
EPS (TTM) | 10.92 |
Earnings date | 23 July 2024 - 29 July 2024 |
Forward dividend & yield | 0.74 (0.46%) |
Ex-dividend date | 29 Feb 2024 |
1y target est | 165.71 |
Universal Health Services (UHS) could produce exceptional returns because of its solid growth attributes.
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.